Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06089902

European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries

Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, and data from multicentre registries are urgently needed to adapt current recommendations and guide optimal patient management. The European Registry for AAOCA (EURO-AAOCA) aims to assess differences with regard to AAOCA management between centres.

Recruiting

Interested in participating?

Request Info

Key information

About this study

EURO AAOCA study database on management for "ANOMALOUS AORTIC ORIGIN OF CORONARY ARTERIES.

This is a simple Excel database in 8 sections (see below). The patient's identification (ID) should be anonymous, and can be decided by each center; the investigators suggest to enclose Centre ID number (which is communicated by the leading center) and a sequential number or date of birth (dd/mm/yy).

If no procedure has been done for the patients , it is required to the "PERIPROCEDURAL, SURGICAL DETAILS" and "POSTPROCEDURAL" data sheets (which are outlined in RED). In the "PERIPROCEDURAL" sheet, the participants may refer either to the surgical or non surgical procedure.

Baseline and long term clinical evaluation sections must be completed for all patients.

In the database, there are lists of multiple different variables which are summarized in tables enclosed in the section, in which each item corresponds to a number.

EURO AAOCA Study DATABASE sections

  • Baseline demo and anatomy: it includes demographic data, and anatomical details for each patient; basic anatomy and course can be selected scrolling an enclosed list; remaining data are requested as yes/no answer
  • Baseline symptoms and indications: it includes symptoms info and indications to surgical/interventional/clinical follow up for each patient; symptoms can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text; in particular, the participants are required to distinguish between recreational non-competitive sports (2-3/week) and Competitive (>5 times/week), Reason for diagnosis in asymptomatic patient can be selected scrolling a list.
  • Baseline instrumental: it includes all possible diagnostic methodologies used for first diagnosis; the test is considered abnormal when it is gives diagnosis of AAOCA, and in this case , the participants are required to describe the findings as precise as possible. In particular, for non-surgical patients, the participants are required to provide a date of the first time any instrumental test suspected AAOCA. ECG data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text
  • Periprocedural: if the patient has gone to surgical or interventional management, the participants are required to fill this section: data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text
  • Surgical details: for surgical patients only, the participants are required to fill this section; data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text
  • Post procedural: for surgical or interventional patients only, the participants are required to fill this section; data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text
  • Follow up 1: this section must be filled for all patients (surgical/interventional /only medical management) and must be updated every year and sent back to the coordinator every June 15th, so as to check yearly the patients. The Investigators suggest an annual follow up for at least 5 years in a row. Follow up data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text. T
  • Follow up Instrumental diagnosis: this section must be filled for all patients (surgical/interventional /only medical management) and must be updated every year and sent back to the coordinator every June 15th, so as to check yearly the patients. The investigators suggest to do this for at least 5 years in a row. Follow up data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up )

Exclusion criteria

  • isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).

Treatment and study plan

unroofing or other surgery if needed

Procedure

unroofing of coronary artery

Other names: clinical follow up

Primary outcomes

  1. Incidence of Symptoms at diagnosis and after surgery

    Time frame: 5 years

    The study will assess the presence of symptoms (angina, chest pain, distress, sudden cardiac death-SCD, syncope, aborted SCD) at diagnosis, and after eventual surgical repair, to assess incidence of symptoms in patients with this anomaly and effectiveness of surgery in removing symptoms.

  2. Incidence of postoperative adverse events

    Time frame: 5 years

    The study will assess the incidence of operative death and adverse events after surgery (in those who undergo surgery).

  3. Incidence of adverse events at follow up

    Time frame: 5 years

    The study will assess the incidence of death and adverse events at clinical follow up either in patients who required a surgical repair or in those who did not undergo surgery because of lack of indications.

Secondary outcomes

  1. Incidence of any arrhythmias at Follow up

    Time frame: 5 years

    The study will assess the incidence of any (mostly ventricular) arrhythmias in all patients, either surgical or non surgical

  2. Rate of return to unrestricted competitive sport

    Time frame: 5 years

    The study will assess the rate of return to unrestricted sport and competitive sport activity in all patients, either surgical or non surgical

Study contacts

Contact information is provided by the study sponsor or research team.

Chris Grani, MD PhD

CONTACT

[email protected]

0041788158858

Massimo Padalino, MD PhD

CONTACT

[email protected]

00393408922564

Sponsors and collaborators

Lead sponsor

University of Padova

Other

Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona
  • Azienda Ospedaliero-Universitaria di Parma
  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain
  • Guy's and St Thomas' NHS Foundation Trust
  • Hospital Universitario La Paz
  • IRCCS Policlinico S. Donato
  • Insel Gruppe AG, University Hospital Bern
  • Mitera Children's Hospital, Athens Heart Surgery Institute, Greece
  • Ospedale Civile Ca' Foncello
  • University Hospital, Ghent
  • University Medical Center Groningen

Registry information

Official study title

EUROAAOCA Registry

Acronym: EUROAAOCA

Important dates

Study start
2019
Primary completion
2025
Study completion
2029
First posted
Oct 19, 2023
Registry last updated
Oct 19, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.